FDMT compared with PCVX: revenue, margins and what each company keeps, and the suppliers and customers both name

FDMT4D Molecular Therapeutics, Inc.

Mkt capRevenueRevenue

PCVXVaxcyte, Inc.

Mkt capRevenueRevenue

Compare

FDMT4D Molecular Therapeutics, Inc.

PCVXVaxcyte, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 501dMethod ›

Moved together

FDMTwithPCVX

×0.24co-movement · PCVX on FDMT · 501d

r 0.32scale to r 0.75

Shared co-movers3with FDMTwith PCVX

CLDXCelldex Therapeutics, Inc.r 0.41r 0.42

XNCRXencor Incr 0.38r 0.36

BEAMBeam Therapeutics Inc.r 0.39r 0.36

FDMT, solidPCVX, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

FDMT4D Molecular Therapeutics, Inc.

11.53▼−3.09%

Mkt cap$858.9MRevenue$4MQ2 FY26

PCVXVaxcyte, Inc.

61.09▼−1.52%

Regular sessionSep 2 '83

Mkt cap$9.2BRevenue—

Compare

Regular sessionSep 2 '83

FDMT4D Molecular Therapeutics, Inc.

PCVXVaxcyte, Inc.

11.53▼−3.09%

Price

61.09▼−1.52%

$858.9M

Mkt cap

$9.2B

Q2 FY26$4M

Revenue

—

FDMT11.53▼−3.09%vsPCVX61.09▼−1.52%Regular sessionSep 2 '83